oxazolidin-2-one and minocycline
oxazolidin-2-one has been researched along with minocycline in 90 studies
Research
Studies (90)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 38 (42.22) | 29.6817 |
2010's | 52 (57.78) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Cartwright, FD; Kenny, GE | 1 |
Ebden, P; Harrison, GA; Lewis, KE; Rees, J; Wooster, SL | 1 |
Miyazaki, S | 1 |
Brenner, GM; Goswick, SM | 1 |
Anstead, GM; Owens, AD | 1 |
de Roux, A; Lode, H; Schmidt-Ioanas, M | 1 |
Chin, JN; LaPlante, KL; Leuthner, KD; Rybak, MJ | 1 |
Hawser, SP | 1 |
Paterson, DL | 1 |
Broelsch, CE; Drühe, N; Gensicke, J; Heuer, M; Malagó, M; Nadalin, S; Radtke, A; Rath, PM; Rüngeler, EM; Saner, FH | 1 |
Abb, J | 1 |
Chaiban, G; Dvorak, T; Hachem, R; Hanna, H; Jiang, Y; Raad, I; Reitzel, R; Sherertz, R | 1 |
Manfredi, R | 1 |
Chambers, HF; Hegde, SS | 1 |
Borbone, S; Campanile, F; Lupo, A; Mezzatesta, ML; Santagati, M; Stefani, S | 1 |
Eder, M; Graninger, W; Hirschl, AM; Lassnigg, A; Presterl, E; Reichmann, S | 1 |
Jenkins, I | 1 |
Martin, CA; Venugopalan, V | 1 |
Anstead, GM; Lewis, JS; Quinones-Nazario, G | 1 |
Loffler, CA; Macdougall, C | 1 |
Ha, NJ; Kim, K; Kim, Y; Lee, DK; Park, KS; Yang, JW | 1 |
Hsueh, PR; Huang, YT; Liao, CH; Teng, LJ | 1 |
Kollef, MH; Micek, ST; Skrupky, LP | 1 |
Aksoy, DY; Unal, S | 1 |
Mazzei, T; Novelli, A | 1 |
Le Moing, V; Makinson, A | 1 |
Akcam, FZ; Kaya, O; Temel, EN | 1 |
Abrahamian, FM; Deblieux, PM; Emerman, CL; Kollef, MH; Kupersmith, E; Leeper, KV; Paterson, DL; Shorr, AF | 1 |
Esposito, S; Leone, S; Noviello, S | 1 |
Chen, M; Liu, Y; Sun, H; Wang, H; Xie, X; Xu, Y | 1 |
Babinchak, T; Beuran, M; Bochan, M; Cooper, CA; Dartois, N; Dimov, R; Dukart, G; Ellis-Grosse, EJ; Fichev, G; Florescu, I; Gandjini, H; Razbadauskas, A | 1 |
Backx, M; Healy, B | 1 |
Decker, CF; Johnson, MD | 1 |
Lee, C | 1 |
Bébéar, C; Dauchy, FA; de Barbeyrac, B; Dupon, M; Dutronc, H; Kuli, B; Mégraud, F | 1 |
Corey, GR; Stryjewski, ME | 1 |
Carnevalini, M; Iannetta, M; Lichtner, M; Mascellino, MT; Massetti, AP; Mastroianni, CM; Mengoni, F; Miccoli, GA; Oliva, A; Russo, G; Trinchieri, V; Vullo, V | 1 |
Cattoir, V; Daurel, C | 1 |
Ellermann-Eriksen, S; Kristensen, L; Rathe, M; Schumacher, H; Thomsen, MK | 1 |
Devasahayam, G; Hoffman, PS; Scheld, WM | 1 |
Concia, E | 1 |
Hennenfent, J; Lambert, BL; McBride, MV; Rodvold, KA; Schiff, G; Schumock, GT; Trese, AM; Tverdek, F; Yang, Y | 1 |
Curcio, D | 1 |
Ippolito, G; Lauria, FN; Leone, S; Nicastri, E; Wenzel, RP | 1 |
Dandekar, G; Dandekar, T | 1 |
Levy, F; Peterson, SM; Reynolds, SA; Sarubbi, FA; Shams, W; Walker, ES | 1 |
Derendorf, H; Estes, KS | 1 |
Dryden, M; Eckmann, C | 1 |
Wilke, MH | 1 |
Diagre, D; Hussain, Z; John, MA; Milburn, S; Stuart, JI; Wilson, B | 1 |
Cauda, R; Esposito, S; Garau, J; Gould, IM; Gudiol, F; Mazzei, T | 1 |
Adam, HJ; Hoban, DJ; Hussain, Z; Kost, S; Lagacé-Wiens, PR; Mataseje, LF; McCracken, M; Mulvey, MR; Nichol, KA; Thompson, K; Zhanel, GG | 1 |
Al-Nawas, B; d'Hoedt, B; Karbach, J; Mouratidou, A | 1 |
Calabuig, E; Salavert, M | 1 |
Chmelařová, E; Dowzicky, MJ | 1 |
Chang, SC; Chen, YC; Kao, TM; Wang, JT; Weng, CM | 1 |
Chen, CC; Chiang, SR; Chuang, YC; Ko, WC; Tang, HJ; Yu, WL | 1 |
Chandrasekar, PH; Kosmidis, CI | 1 |
Cleveland, KO; Gelfand, MS; Twilla, JD; Usery, JB | 1 |
Sancak, B | 1 |
Bania, J; Dolna, I; Dworniczek, E; Gościniak, G; Kowalska-Krochmal, B; Seniuk, A; Wałecka, E | 1 |
Badiou, C; Couet, W; Lina, G; Pantrangi, M; Pichereau, S; Rose, WE; Shukla, SK | 1 |
Dowzicky, MJ | 1 |
Cesur, S; Demiröz, AP; Irmak, H; Karakoç, E; Kınıklı, S; Pelitli, TS | 1 |
Dowzicky, MJ; Namdari, H; Tan, TY | 1 |
Betriu, C; Canut, A; Gascón, AR; Isla, A | 1 |
Chen, CM; Chen, WY; Chen, YH; Chen, YS; Cheng, YJ; Chiang, PC; Chuang, YC; Hsu, GJ; Hsueh, PR; Huang, CH; Jang, TN; Ko, WC; Kung, HC; Lee, CM; Lee, MH; Liao, CH; Lin, HC; Liu, CE; Liu, JW; Liu, YC; Lu, CT; Lu, PL; Pan, SC; Shi, ZY; Sun, W; Tsai, HY; Tsao, SM; Wang, LS; Yang, JL; Yu, KW | 1 |
Aznar, J; Dowzicky, MJ; Lepe, JA | 1 |
Arbeit, RD; Draper, MP; Hait, H; Noel, GJ; Tanaka, SK | 1 |
Arslan, U; Aydın, F; Bayramoğlu, G; Baysan, BO; Berktaş, M; Cesur, S; Cöplü, N; Demiröz, AP; Esen, B; Gencer, S; Gülay, Z; Hoşoğlu, S; Irmak, H; Karabiber, N; Kılıç, H; Simşek, H; Yalçın, AN | 1 |
Gonoi, T; Hayashi, S; Kimura, S; Kobayashi, N; Kusaba, K; Naganobu, N; Nagasawa, Z; Sueoka-Aragane, N; Umeguchi, H; Yazawa, K | 1 |
Buntaran, L; Dwiyanti, R; Hatta, M; Sabir, M; Sultan, AR | 1 |
Rutala, WA; Weber, DJ | 1 |
Carrer, DP; Giamarellou, H; Pefanis, A; Pontikis, K; Tsaganos, T; Tzepi, IM | 1 |
Beaume, M; Francois, P; Harrison, PF; Hernandez, D; Howden, BP; Schrenzel, J; Seemann, T; Stinear, TP | 1 |
Champion, EA; Hobbs, MM; Miller, MB; Muhlebach, MS; Popowitch, EB; Saiman, L | 1 |
Synold, T; Wong-Beringer, A; Yamaki, J | 1 |
Jiang, TT; Li, L; Su, JR; Wu, J | 1 |
Erdogan-Yildirim, Z; Manafi, M; Sauermann, R; Schwameis, R; Strommer, S; Zeitlinger, MA | 1 |
Ibrahim, SA; Noreddin, AM; Salem, AH; Zhanel, GG | 1 |
Abduljaleel, SA; Atshan, SS; Awang Hamat, R; Ghaznavi-Rad, E; Jeevajothi Nathan, J; Karunanidhi, A; Lung, LT; Mateg Ali, A; Nor Shamsudin, M; Pei Pei, C; Sekawi, Z | 1 |
Muscedere, J | 1 |
Holmberg, A; Rasmussen, M | 1 |
Alves, SH; Loreto, ES; Pilotto, MB; Santurio, JM; Tondolo, JS | 1 |
Coato, P; Cojutti, P; Pea, F; Rigoli, R; Sartor, A; Scarparo, C | 1 |
Mischnik, A; Mutters, NT; Tacconelli, E; Werner, G | 1 |
Bodmann, KF; Mutters, R | 1 |
Mischnik, A; Mutters, NT | 1 |
Concia, E; Falcone, M; Giusti, M; Mazzone, A; Santini, C; Stefani, S; Violi, F | 1 |
Arthur, M; Compain, F; Dorchène, D; Dubée, V; Gaillard, JL; Herrmann, JL; Heym, B; Soroka, D | 1 |
Reviews
31 review(s) available for oxazolidin-2-one and minocycline
Article | Year |
---|---|
[Other antimicrobial agents (linezolid, quinupristin/dalfopristin, glycylcycline etc)].
Topics: Acetamides; Bacteria; Drug Design; Drug Resistance, Bacterial; Humans; Linezolid; Minocycline; Oxazolidinones; Tetracyclines; Tigecycline; Virginiamycin | 2003 |
Recent advances in the treatment of infections due to resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Multiple, Bacterial; Glycopeptides; Humans; Linezolid; Lipoglycopeptides; Minocycline; Oxazolidinones; Staphylococcal Infections; Teicoplanin; Tigecycline; Virginiamycin | 2004 |
New antibiotics for the treatment of severe staphylococcal infection in the critically ill patient.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Clinical Trials as Topic; Critical Illness; Daptomycin; Drug Resistance, Multiple, Bacterial; Glycopeptides; Humans; Linezolid; Lipoglycopeptides; Methicillin Resistance; Minocycline; Oxazolidinones; Staphylococcal Infections; Teicoplanin; Tigecycline; Virginiamycin | 2005 |
Clinical experience with recently approved antibiotics.
Topics: Acetamides; Anti-Bacterial Agents; Bacterial Infections; Daptomycin; Humans; Linezolid; Minocycline; Oxazolidinones; Staphylococcal Infections; Streptococcal Infections; Tigecycline; Virginiamycin | 2006 |
[Therapeutic perspectives of linezolid in the management of infections due to multiresistant Gram-positive pathogens].
Topics: Acetamides; Administration, Oral; Anti-Infective Agents; Daptomycin; Drug Resistance, Multiple, Bacterial; Enterococcus; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Injections, Intravenous; Linezolid; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Practice Guidelines as Topic; Staphylococcus aureus; Streptococcus pneumoniae; Teicoplanin; Tigecycline; Time Factors; Vancomycin; Virginiamycin | 2007 |
Combating the growing problem of methicillin-resistant Staphylococcus aureus: do the newer antibiotics represent a better alternative to vancomycin?
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Linezolid; Methicillin Resistance; Minocycline; Oxazolidinones; Staphylococcus aureus; Tigecycline; Vancomycin; Virginiamycin | 2007 |
Selecting anti-infective agents for the treatment of bone infections: new anti-infective agents and chronic suppressive therapy.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Bone Diseases, Infectious; Daptomycin; Humans; Linezolid; Minocycline; Osteomyelitis; Oxazolidinones; Tigecycline | 2007 |
Treatment of infections caused by resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Humans; Linezolid; Methicillin Resistance; Minocycline; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Tigecycline; Vancomycin; Virginiamycin | 2007 |
Optimizing therapy for MRSA pneumonia.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Daptomycin; Humans; Linezolid; Methicillin Resistance; Minocycline; Oxazolidinones; Pneumonia, Bacterial; Staphylococcus aureus; Tigecycline; Vancomycin | 2007 |
New antimicrobial agents for the treatment of Gram-positive bacterial infections.
Topics: Acetamides; Anti-Infective Agents; Cephalosporins; Daptomycin; Glycopeptides; Gram-Positive Bacterial Infections; Linezolid; Minocycline; Oxazolidinones; Tigecycline; Virginiamycin | 2008 |
[Pharmacological rationale for choice of antibiotics for intraabdominal infections].
Topics: Abdominal Abscess; Acetamides; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Digestive System Diseases; Drug Therapy, Combination; Fluoroquinolones; Humans; Linezolid; Metronidazole; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Peritonitis; Sepsis; Tigecycline; Treatment Outcome; Virginiamycin | 2008 |
[New anti-Gram+antibiotics: which role in infective endocarditis?].
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Endocarditis; Gram-Positive Bacterial Infections; Humans; Linezolid; Minocycline; Oxazolidinones; Tigecycline; Virginiamycin | 2008 |
Health care-associated pneumonia: identification and initial management in the ED.
Topics: Acetamides; Age Distribution; Aged; Aged, 80 and over; Anti-Infective Agents; beta-Lactams; Cephalosporins; Cross Infection; Emergency Treatment; Ertapenem; Female; Humans; Length of Stay; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Oxazolidinones; Patient Care Team; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Practice Guidelines as Topic; Respiration, Artificial; Risk Factors; Severity of Illness Index; Tigecycline | 2008 |
[Skin and soft tissue infections: current therapeutic options].
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Daptomycin; Humans; Linezolid; Methicillin Resistance; Middle Aged; Minocycline; Oxazolidinones; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Skin Diseases, Infectious; Soft Tissue Infections; Staphylococcal Skin Infections; Staphylococcus aureus; Tigecycline; Time Factors; Treatment Outcome | 2008 |
Serious staphylococcal infections.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Daptomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Minocycline; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Tigecycline; Vancomycin Resistance | 2008 |
Antimicrobial agents in treatment of MRSA infections.
Topics: Acetamides; Anti-Bacterial Agents; Cephalosporins; Clindamycin; Community-Acquired Infections; Daptomycin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fluoroquinolones; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Minocycline; Oxazolidinones; Staphylococcal Infections; Teicoplanin; Tetracyclines; Tigecycline; Trimethoprim, Sulfamethoxazole Drug Combination; United States; Vancomycin | 2008 |
Therapeutic challenges in the era of antibiotic resistance.
Topics: Acetamides; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Daptomycin; Drug Resistance, Microbial; Humans; Linezolid; Minocycline; Oxazolidinones; Tigecycline | 2008 |
New treatments for methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Cephalosporins; Clinical Trials as Topic; Daptomycin; Evidence-Based Medicine; Glycopeptides; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Minocycline; Oxazolidinones; Pyrimidines; Streptococcal Infections; Tigecycline | 2009 |
[Update on antimicrobial chemotherapy].
Topics: Acetamides; Aminoglycosides; Anti-Infective Agents; beta-Lactams; Carbapenems; Cephalosporins; Daptomycin; Doripenem; Drug Resistance, Bacterial; Ertapenem; Fluoroquinolones; France; Humans; Linezolid; Lipoglycopeptides; Minocycline; Oxazolidinones; Penicillins; Pyrimidines; Teicoplanin; Tigecycline | 2010 |
Newer antibacterial drugs for a new century.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; Drug Delivery Systems; Drug Discovery; Drug Evaluation, Preclinical; Drug Resistance, Bacterial; Drugs, Investigational; Glycopeptides; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Macrolides; Minocycline; Oxazolidinones; Tigecycline | 2010 |
[Therapy of SSTI and role of tigecycline].
Topics: Acetamides; Anti-Bacterial Agents; Combined Modality Therapy; Comorbidity; Cross Infection; Daptomycin; Debridement; Drainage; Drug Therapy, Combination; Humans; Italy; Linezolid; Minocycline; Oxazolidinones; Practice Guidelines as Topic; Sepsis; Skin Diseases, Bacterial; Soft Tissue Infections; Tigecycline; Wound Infection | 2009 |
Resistant pathogen-associated skin and skin-structure infections: antibiotic options.
Topics: Acetamides; Anti-Bacterial Agents; Carbapenems; Daptomycin; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Minocycline; Oxazolidinones; Skin Diseases, Bacterial; Tigecycline; Treatment Outcome | 2010 |
Methicillin-resistant Staphylococcus aureus: the superbug.
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Cross Infection; Daptomycin; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Minocycline; Oxazolidinones; Staphylococcal Infections; Tigecycline; Treatment Outcome | 2010 |
Treatment of complicated skin and soft-tissue infections caused by resistant bacteria: value of linezolid, tigecycline, daptomycin and vancomycin.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Microbial; Humans; Linezolid; Minocycline; Oxazolidinones; Skin Diseases; Soft Tissue Infections; Tigecycline; Vancomycin | 2010 |
Multiresistant bacteria and current therapy - the economical side of the story.
Topics: Acetamides; Anti-Bacterial Agents; Carbapenems; Daptomycin; Doripenem; Drug Resistance, Microbial; Drug Resistance, Multiple; Economics, Pharmaceutical; Linezolid; Minocycline; Oxazolidinones; Tigecycline | 2010 |
Management of serious meticillin-resistant Staphylococcus aureus infections: what are the limits?
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Daptomycin; Endocarditis, Bacterial; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Pneumonia, Bacterial; Staphylococcal Infections; Teicoplanin; Tigecycline; Treatment Outcome; Vancomycin | 2011 |
Management of gram-positive bacterial infections in patients with cancer.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Lipoglycopeptides; Minocycline; Neoplasms; Oxazolidinones; Tigecycline | 2012 |
[Staphylococcus aureus and antibiotic resistance].
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Minocycline; Oxazolidinones; Protein Synthesis Inhibitors; Staphylococcal Infections; Teicoplanin; Tigecycline; Vancomycin; Vancomycin Resistance; Virginiamycin | 2011 |
New antibiotic agents: problems and prospects.
Topics: Acetamides; Acinetobacter; Anti-Bacterial Agents; Cross Infection; Daptomycin; Drug Resistance, Multiple, Bacterial; Humans; Ketolides; Linezolid; Methicillin-Resistant Staphylococcus aureus; Minocycline; Oxazolidinones; Pseudomonas aeruginosa; Surgical Wound Infection; Tigecycline; Vancomycin Resistance | 2005 |
[Treatment options for serious infections caused by vancomycin-resistant enterococci].
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Enterobacteriaceae; Evidence-Based Medicine; Gram-Positive Bacterial Infections; Humans; Linezolid; Minocycline; Oxazolidinones; Tigecycline; Treatment Outcome; Vancomycin-Resistant Enterococci | 2015 |
Acute bacterial skin and skin structure infections in internal medicine wards: old and new drugs.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Ceftaroline; Cephalosporins; Daptomycin; Female; Fluoroquinolones; Glycopeptides; Hospitalization; Humans; Iatrogenic Disease; Internal Medicine; Linezolid; Lipoglycopeptides; Male; Minocycline; Oxazolidinones; Skin Diseases, Infectious; Soft Tissue Infections; Teicoplanin; Tigecycline; Vancomycin | 2016 |
Trials
2 trial(s) available for oxazolidin-2-one and minocycline
Article | Year |
---|---|
Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study.
Topics: Acetamides; Aged; Anti-Bacterial Agents; Cross Infection; Double-Blind Method; Enterococcus; Female; Gram-Positive Bacterial Infections; Hospitalization; Humans; Linezolid; Male; Methicillin Resistance; Middle Aged; Minocycline; Oxazolidinones; Staphylococcus aureus; Tigecycline; Treatment Outcome; Vancomycin; Vancomycin Resistance | 2008 |
A randomized, evaluator-blind, phase 2 study comparing the safety and efficacy of omadacycline to those of linezolid for treatment of complicated skin and skin structure infections.
Topics: Acetamides; Adolescent; Adult; Aged; Anti-Bacterial Agents; Aztreonam; Drug Administration Schedule; Female; Humans; Injections, Intravenous; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Minocycline; Oxazolidinones; Placebos; Skin; Skin Diseases, Bacterial; Staphylococcal Infections; Treatment Outcome | 2012 |
Other Studies
57 other study(ies) available for oxazolidin-2-one and minocycline
Article | Year |
---|---|
Susceptibilities of Mycoplasma hominis, M. pneumoniae, and Ureaplasma urealyticum to GAR-936, dalfopristin, dirithromycin, evernimicin, gatifloxacin, linezolid, moxifloxacin, quinupristin-dalfopristin, and telithromycin compared to their susceptibilities
Topics: 4-Quinolones; Acetamides; Aminoglycosides; Anti-Bacterial Agents; Aza Compounds; Erythromycin; Fluoroquinolones; Gatifloxacin; Humans; Hydrogen-Ion Concentration; Ketolides; Linezolid; Macrolides; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Mycoplasma hominis; Mycoplasma pneumoniae; Oxazolidinones; Quinolines; Tetracyclines; Tigecycline; Ureaplasma urealyticum; Virginiamycin | 2001 |
Multi-system Infection with Nocardia farcinica-therapy with linezolid and minocycline.
Topics: Acetamides; Brain; Drug Resistance, Multiple, Bacterial; Humans; Linezolid; Magnetic Resonance Imaging; Male; Minocycline; Nocardia; Nocardia Infections; Oxazolidinones | 2003 |
Activities of therapeutic agents against Naegleria fowleri in vitro and in a mouse model of primary amebic meningoencephalitis.
Topics: Acetamides; Adolescent; Amebiasis; Amebicides; Amphotericin B; Animals; Central Nervous System Protozoal Infections; Disease Models, Animal; Drug Therapy, Combination; Female; Humans; Ketoconazole; Linezolid; Liposomes; Male; Mice; Minocycline; Naegleria fowleri; Oxazolidinones; Trifluoperazine; Virginiamycin | 2003 |
Impact of Enterococcus faecalis on the bactericidal activities of arbekacin, daptomycin, linezolid, and tigecycline against methicillin-resistant Staphylococcus aureus in a mixed-pathogen pharmacodynamic model.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Daptomycin; Dibekacin; Enterococcus faecalis; Humans; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Staphylococcus aureus; Tigecycline | 2006 |
Antibacterial drug discovery and development--SRI's 11th Annual Summit.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Cephalosporins; Clinical Trials as Topic; Drug Design; Humans; Incidence; Lipoglycopeptides; Methicillin Resistance; Minocycline; Molecular Structure; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Thiazoles; Tigecycline | 2006 |
Successful salvage therapy with tigecycline after linezolid failure in a liver transplant recipient with MRSA pneumonia.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Humans; Linezolid; Liver Transplantation; Male; Methicillin Resistance; Middle Aged; Minocycline; Oxazolidinones; Pneumonia, Staphylococcal; Salvage Therapy; Staphylococcus aureus; Tigecycline; Treatment Failure; Treatment Outcome | 2006 |
In vitro activities of tigecycline, daptomycin, linezolid and quinupristin/dalfopristin against glycopeptide-resistant Enterococcus faecium.
Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Daptomycin; Drug Resistance, Bacterial; Enterococcus faecium; Glycopeptides; Gram-Positive Bacterial Infections; Humans; In Vitro Techniques; Linezolid; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Tigecycline; Virginiamycin | 2007 |
Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm.
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Biofilms; Catheterization, Central Venous; Daptomycin; Humans; Linezolid; Methicillin Resistance; Minocycline; Oxazolidinones; Staphylococcus aureus; Tigecycline | 2007 |
Evaluation of the in vitro activity of tigecycline against multiresistant Gram-positive cocci containing tetracycline resistance determinants.
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Enterococcus; Genes, Bacterial; Humans; Linezolid; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Staphylococcus; Streptococcus; Tetracycline Resistance; Tigecycline; Virginiamycin | 2008 |
Effects of tigecycline, linezolid and vancomycin on biofilms of viridans streptococci isolates from patients with endocarditis.
Topics: Acetamides; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Biofilms; Dose-Response Relationship, Drug; Endocarditis, Bacterial; Female; Heart Valve Prosthesis; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Oxazolidinones; Prosthesis-Related Infections; Streptococcal Infections; Tigecycline; Treatment Outcome; Vancomycin; Viridans Streptococci | 2007 |
Linezolid- and vancomycin-resistant Enterococcus faecium endocarditis: successful treatment with tigecycline and daptomycin.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Minocycline; Oxazolidinones; Tigecycline; Treatment Outcome; Vancomycin | 2007 |
Update on prevalence and treatment of methicillin-resistant Staphylococcus aureus infections.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Clindamycin; Daptomycin; Doxycycline; Folic Acid Antagonists; Global Health; Glycopeptides; Humans; Linezolid; Lipoglycopeptides; Methicillin; Methicillin Resistance; Minocycline; Oxazolidinones; Prevalence; Staphylococcal Infections; Staphylococcus aureus; Sulfamethoxazole; Teicoplanin; Tigecycline; Trimethoprim; Vancomycin | 2007 |
Antimicrobial activity of mupirocin, daptomycin, linezolid, quinupristin/dalfopristin and tigecycline against vancomycin-resistant enterococci (VRE) from clinical isolates in Korea (1998 and 2005).
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Korea; Linezolid; Microbial Sensitivity Tests; Minocycline; Mupirocin; Oxazolidinones; Tigecycline; Vancomycin Resistance; Virginiamycin | 2007 |
Comparative bactericidal activities of daptomycin, glycopeptides, linezolid and tigecycline against blood isolates of Gram-positive bacteria in Taiwan.
Topics: Acetamides; Anti-Infective Agents; Daptomycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Glycopeptides; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Linezolid; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Staphylococcus aureus; Streptococcaceae; Taiwan; Teicoplanin; Tigecycline; Time Factors; Vancomycin | 2008 |
In vitro activities of linezolid and tigecycline against methicillin-resistant Staphylococcus aureus strains.
Topics: Acetamides; Anti-Infective Agents; Cross Infection; Humans; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Tigecycline; Turkey | 2008 |
In vitro activity of ceftobiprole, linezolid, tigecycline, and 23 other antimicrobial agents against Staphylococcus aureus isolates in China.
Topics: Acetamides; Anti-Bacterial Agents; Cephalosporins; China; Humans; Linezolid; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Prevalence; Staphylococcal Infections; Staphylococcus aureus; Tigecycline | 2008 |
In vitro activities of daptomycin, tigecycline, linezolid and eight other antibiotics, alone and in combination, against 41 Staphylococcus spp. clinical isolates from bone and joint infections.
Topics: Acetamides; Anti-Bacterial Agents; Arthritis, Infectious; Bone and Bones; Daptomycin; Drug Synergism; Humans; Joints; Linezolid; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Staphylococcal Infections; Staphylococcus; Tigecycline | 2009 |
Primary retroperitoneal abscesses due to Rhodococcus equi in a patient with severe nephrotic syndrome: successful antibiotic treatment with linezolid and tigecycline.
Topics: Abdominal Abscess; Acetamides; Actinomycetales Infections; Adult; Anti-Bacterial Agents; Drug Therapy, Combination; Humans; Immunocompromised Host; Injections, Intravenous; Linezolid; Male; Microbial Sensitivity Tests; Minocycline; Nephrotic Syndrome; Oxazolidinones; Retroperitoneal Space; Rhodococcus equi; Tigecycline; Treatment Outcome | 2010 |
Vancomycin-resistant Enterococcus spp.: validation of susceptibility testing and in vitro activity of vancomycin, linezolid, tigecycline and daptomycin.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Daptomycin; DNA, Bacterial; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Polymerase Chain Reaction; Reproducibility of Results; Tigecycline; Vancomycin; Vancomycin Resistance | 2010 |
Hospital policies and practices on prevention and treatment of infections caused by methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Clinical Protocols; Daptomycin; Formularies, Hospital as Topic; Guidelines as Topic; Health Care Surveys; Hospitals; Humans; Infection Control; Linezolid; Methicillin-Resistant Staphylococcus aureus; Minocycline; Organizational Policy; Oxazolidinones; Patient Isolation; Pharmacy Service, Hospital; Staphylococcal Infections; Surveys and Questionnaires; Tigecycline; Vancomycin | 2010 |
Pharmacogenomic strategies against microbial resistance: from bright to bleak to innovative.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Bacterial Infections; Computational Biology; Daptomycin; Drug Delivery Systems; Drug Resistance, Microbial; Drug Resistance, Multiple, Bacterial; Forecasting; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Linezolid; Minocycline; Oxazolidinones; Pharmacogenetics; Systems Biology; Tigecycline; Virginiamycin | 2010 |
Comparative activity of telavancin and other antimicrobial agents against methicillin-resistant Staphylococcus aureus isolates collected from 1991 to 2006.
Topics: Acetamides; Aminoglycosides; Anti-Infective Agents; Daptomycin; Linezolid; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Tigecycline; Vancomycin | 2010 |
Comparison of the pharmacokinetic properties of vancomycin, linezolid, tigecyclin, and daptomycin.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Humans; Linezolid; Minocycline; Oxazolidinones; Tigecycline; Vancomycin | 2010 |
Susceptibility patterns of coagulase-negative staphylococci to several newer antimicrobial agents in comparison with vancomycin and oxacillin.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; Daptomycin; DNA, Ribosomal; Linezolid; Lipoglycopeptides; Microbial Sensitivity Tests; Micrococcal Nuclease; Minocycline; Oxacillin; Oxazolidinones; Penicillin-Binding Proteins; Polymerase Chain Reaction; Staphylococcus; Tigecycline; Vancomycin | 2011 |
Comparison of community-associated and health care-associated methicillin-resistant Staphylococcus aureus in Canada: results of the CANWARD 2007-2009 study.
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Toxins; Canada; Child; Child, Preschool; Community-Acquired Infections; Cross Infection; Daptomycin; DNA, Bacterial; Drug Resistance, Bacterial; Exotoxins; Female; Hospitals; Humans; Infant; Leukocidins; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Minocycline; Oxazolidinones; Staphylococcal Infections; Tigecycline; Vancomycin Resistance | 2011 |
Antibiotic susceptibility of cocultures in polymicrobial infections such as peri-implantitis or periodontitis: an in vitro model.
Topics: Acetamides; Actinobacillus Infections; Aggregatibacter actinomycetemcomitans; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Azithromycin; Capnocytophaga; Coculture Techniques; Coinfection; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Linezolid; Metronidazole; Microbial Interactions; Minocycline; Moxifloxacin; Oxazolidinones; Penicillin G; Peptostreptococcus; Peri-Implantitis; Periodontitis; Quinolines; Sulbactam | 2011 |
[Role of daptomycin in the treatment of infections in patients with hematological malignancies].
Topics: Acetamides; Anti-Bacterial Agents; Antineoplastic Agents; Daptomycin; Databases, Factual; Europe; Glycopeptides; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Humans; Immunocompromised Host; Kidney Diseases; Linezolid; Microbial Sensitivity Tests; Minocycline; Multicenter Studies as Topic; Neutropenia; Oxazolidinones; Registries; Retrospective Studies; Risk Factors; Tigecycline; Treatment Outcome | 2010 |
Global in vitro activity of tigecycline and linezolid against Gram-positive organisms collected between 2004 and 2009.
Topics: Acetamides; Anti-Bacterial Agents; Czech Republic; Enterococcus; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Staphylococcus aureus; Streptococcus pneumoniae; Tigecycline | 2011 |
In vitro activity of linezolid, tigecycline, and daptomycin on methicillin-resistant Staphylococcus aureus blood isolates from adult patients, 2006-2008: stratified analysis by vancomycin MIC.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Bacteremia; Blood; Daptomycin; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Staphylococcal Infections; Taiwan; Tigecycline; Vancomycin | 2011 |
In vitro efficacy of antimicrobial agents against high-inoculum or biofilm-embedded meticillin-resistant Staphylococcus aureus with vancomycin minimal inhibitory concentrations equal to 2 μg/mL (VA2-MRSA).
Topics: Acetamides; Anti-Infective Agents; Biofilms; Drug Synergism; Drug Therapy, Combination; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Stem Cells; Tigecycline; Vancomycin | 2011 |
Telavancin for the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Daptomycin; Humans; Linezolid; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Minocycline; Osteomyelitis; Oxazolidinones; Staphylococcal Infections; Tigecycline; Vancomycin | 2011 |
Resistance patterns and occurrence of virulence determinants among GRE strains in southwestern Poland.
Topics: Acetamides; Agar; Anti-Bacterial Agents; Biofilms; Daptomycin; Deoxyribonucleases; Drug Resistance; Drug Resistance, Bacterial; Enterococcus; Gelatinases; Glycopeptides; Hemolysin Proteins; Hospitalization; Humans; Linezolid; Lipase; Minocycline; Norfloxacin; Oxazolidinones; Phenotype; Poland; Tigecycline; Virulence | 2011 |
Simulated antibiotic exposures in an in vitro hollow-fiber infection model influence toxin gene expression and production in community-associated methicillin-resistant Staphylococcus aureus strain MW2.
Topics: Acetamides; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Cell Culture Techniques; Clindamycin; Community-Acquired Infections; Enzyme-Linked Immunosorbent Assay; Exotoxins; Gene Expression Regulation, Bacterial; Humans; Leukocidins; Leukocytes, Mononuclear; Linezolid; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Models, Biological; Oxazolidinones; Real-Time Polymerase Chain Reaction; Staphylococcal Infections; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin; Virulence Factors | 2012 |
Susceptibility to tigecycline and linezolid among gram-positive isolates collected in the United States as part of the tigecycline evaluation and surveillance trial (TEST) between 2004 and 2009.
Topics: Acetamides; Anti-Infective Agents; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Streptococcus pneumoniae; Tigecycline; Treatment Outcome; United States; Vancomycin Resistance | 2011 |
[Evaluation of vancomycin, teicoplanin, linezolide and tigecycline susceptibilities of nosocomial methicillin-resistant Staphylococcus strains by E-test].
Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Staphylococcal Infections; Teicoplanin; Tigecycline; Turkey; Vancomycin | 2011 |
Activity of tigecycline and comparators against skin and skin structure pathogens: global results of the Tigecycline evaluation and surveillance trial, 2004-2009.
Topics: Acetamides; Acinetobacter baumannii; Carbapenems; Drug Evaluation; Drug Resistance, Bacterial; Enterococcus faecalis; Enterococcus faecium; Humans; Klebsiella pneumoniae; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Skin; Skin Diseases, Bacterial; Tigecycline; Vancomycin | 2012 |
Pharmacokinetic-pharmacodynamic evaluation of daptomycin, tigecycline, and linezolid versus vancomycin for the treatment of MRSA infections in four western European countries.
Topics: Acetamides; Anti-Bacterial Agents; Belgium; Daptomycin; Ireland; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Spain; Staphylococcal Infections; Tigecycline; United Kingdom; Vancomycin | 2012 |
Trends in susceptibility of vancomycin-resistant Enterococcus faecium to tigecycline, daptomycin, and linezolid and molecular epidemiology of the isolates: results from the Tigecycline In Vitro Surveillance in Taiwan (TIST) study, 2006 to 2010.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Linezolid; Microbial Sensitivity Tests; Minocycline; Molecular Epidemiology; Oxazolidinones; Taiwan; Tigecycline; Vancomycin Resistance | 2012 |
Antimicrobial susceptibility among E. faecalis and E. faecium from France, Germany, Italy, Spain and the UK (T.E.S.T. Surveillance Study, 2004-2009).
Topics: Acetamides; Anti-Infective Agents; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Enterococcus faecium; France; Germany; Humans; Italy; Linezolid; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Spain; Tigecycline | 2012 |
[Evaluation of antibiotic susceptibilities and VISA-VRSA rates among MRSA strains isolated from hospitalized patients in intensive care units of hospitals in seven provinces of Turkey].
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Humans; Intensive Care Units; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Staphylococcal Infections; Teicoplanin; Tigecycline; Turkey; Vancomycin; Vancomycin Resistance; Virginiamycin | 2012 |
Disseminated Nocardiosis caused by Nocardia concava with acute respiratory failure and central nervous system involvement treated with linezolid.
Topics: Acetamides; Acute Disease; Aged; Anti-Bacterial Agents; Central Nervous System Diseases; Humans; Immunocompromised Host; Linezolid; Male; Microbial Sensitivity Tests; Minocycline; Nocardia; Nocardia Infections; Oxazolidinones; Respiratory Insufficiency; Trimethoprim, Sulfamethoxazole Drug Combination | 2012 |
Sccmec type II gene is common among clinical isolates of methicillin-resistant Staphylococcus aureus in Jakarta, Indonesia.
Topics: Acetamides; Amikacin; Clindamycin; Community-Acquired Infections; Cross Infection; DNA Primers; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Humans; Indonesia; Linezolid; Methicillin-Resistant Staphylococcus aureus; Minocycline; Oxazolidinones; Plasmids; Polymerase Chain Reaction; Species Specificity; Teicoplanin; Tigecycline; Time Factors; Vancomycin | 2013 |
Efficacy of tigecycline alone and in combination with gentamicin in the treatment of experimental endocarditis due to linezolid-resistant Enterococcus faecium.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecium; Gentamicins; Gram-Positive Bacterial Infections; Linezolid; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Rabbits; Tigecycline | 2013 |
Analysis of the small RNA transcriptional response in multidrug-resistant Staphylococcus aureus after antimicrobial exposure.
Topics: Acetamides; Anti-Bacterial Agents; Cephalosporins; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Protein Biosynthesis; RNA, Bacterial; RNA, Messenger; RNA, Small Untranslated; Sequence Analysis, RNA; Tigecycline; Transcription, Genetic; Vancomycin | 2013 |
Antimicrobial susceptibility and molecular typing of MRSA in cystic fibrosis.
Topics: Acetamides; Adolescent; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Bronchoscopy; Child; Child, Preschool; Cohort Studies; Cystic Fibrosis; DNA, Bacterial; Exotoxins; Female; Fosfomycin; Fusidic Acid; Humans; Leukocidins; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Molecular Typing; Mupirocin; Oxazolidinones; Penicillin-Binding Proteins; Pharynx; Pneumonia, Staphylococcal; Sequence Analysis, DNA; Sputum; Staphylococcal Infections; Staphylococcal Protein A; Tetracycline; Tigecycline; Trimethoprim, Sulfamethoxazole Drug Combination; United States | 2014 |
Tigecycline induction of phenol-soluble modulins by invasive methicillin-resistant Staphylococcus aureus strains.
Topics: Acetamides; Anti-Bacterial Agents; Bacterial Toxins; Clindamycin; Culture Media; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Protein Isoforms; Staphylococcal Infections; Tigecycline | 2013 |
Antimicrobial activity of linezolid combined with minocycline against vancomycin-resistant Enterococci.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Drug Therapy, Combination; Enterococcus; Linezolid; Microbial Sensitivity Tests; Minocycline; Mutation; Oxazolidinones; Vancomycin Resistance | 2013 |
Effect of pulmonary surfactant on antimicrobial activity in vitro.
Topics: Acetamides; Animals; Anti-Infective Agents; Aza Compounds; Carbapenems; Colistin; Daptomycin; Doripenem; Fluoroquinolones; Linezolid; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Oxazolidinones; Pulmonary Surfactants; Quinolines; Staphylococcus aureus; Swine; Tigecycline | 2013 |
Monte Carlo simulation analysis of ceftobiprole, dalbavancin, daptomycin, tigecycline, linezolid and vancomycin pharmacodynamics against intensive care unit-isolated methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Cephalosporins; Computer Simulation; Cross Infection; Daptomycin; Dose-Response Relationship, Drug; Humans; Intensive Care Units; Linezolid; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Minocycline; Models, Biological; Monte Carlo Method; Oxazolidinones; Staphylococcal Infections; Teicoplanin; Tigecycline; Vancomycin | 2014 |
Genotypically different clones of Staphylococcus aureus are diverse in the antimicrobial susceptibility patterns and biofilm formations.
Topics: Acetamides; Anti-Infective Agents; Biofilms; Daptomycin; Genetic Variation; Genotype; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Viability; Minocycline; Oxazolidinones; Staphylococcal Infections; Tigecycline; Vancomycin | 2013 |
Which antibiotic for hospital acquired pneumonia caused by MRSA?
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Cross Infection; Daptomycin; Humans; Linezolid; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Minocycline; Oxazolidinones; Pneumonia, Staphylococcal; Tigecycline; Vancomycin; Virginiamycin | 2014 |
Antibiotic regimens with rifampicin for treatment of Enterococcus faecium in biofilms.
Topics: Acetamides; Anti-Bacterial Agents; Bacterial Adhesion; Biofilms; Bone Cements; Daptomycin; Drug Combinations; Drug Resistance, Bacterial; Enterococcus faecium; Linezolid; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Rifampin; Tigecycline | 2014 |
New insights into the in vitro susceptibility of Pythium insidiosum.
Topics: Acetamides; Anti-Bacterial Agents; Antifungal Agents; Azithromycin; Clarithromycin; Doxycycline; Linezolid; Microbial Sensitivity Tests; Minocycline; Mupirocin; Oxazolidinones; Pythium; Tigecycline | 2014 |
A 5-year survey of antimicrobial susceptibility profiles of methicillin-resistant Staphylococcus aureus (MRSA) isolated from patients with bloodstream infections in Northeast Italy.
Topics: Acetamides; Anti-Bacterial Agents; Blood; Daptomycin; Health Surveys; Humans; Italy; Linezolid; Longitudinal Studies; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Staphylococcal Infections; Teicoplanin; Tigecycline; Vancomycin | 2015 |
[Vancomycin-resistant enterococci: increased mortality with tigecyclin?].
Topics: Acetamides; Daptomycin; Gram-Positive Bacterial Infections; Humans; Minocycline; Oxazolidinones; Vancomycin-Resistant Enterococci | 2015 |
[Vancomycin-resistant enterococci: increased mortality with tigecycline?].
Topics: Acetamides; Daptomycin; Gram-Positive Bacterial Infections; Humans; Minocycline; Oxazolidinones; Vancomycin-Resistant Enterococci | 2015 |
In vitro activity of tedizolid against the Mycobacterium abscessus complex.
Topics: Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Linezolid; Microbial Sensitivity Tests; Minocycline; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Oxazolidinones; Tetrazoles; Tigecycline | 2018 |